This paper is in the following e-collection/theme issue:

NIH funded proposals with peer-review reports (USA) (76) Pharmacology and Pharmaceutics (66) Gastroenterology and Hepatology (68)

Published on in Vol 13 (2024)

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/50513, first published .
Safety, Tolerability, and Dose-Limiting Toxicity of Lacosamide in Patients With Painful Chronic Pancreatitis: Protocol for a Phase 1 Clinical Trial to Determine Safety and Identify Side Effects

Safety, Tolerability, and Dose-Limiting Toxicity of Lacosamide in Patients With Painful Chronic Pancreatitis: Protocol for a Phase 1 Clinical Trial to Determine Safety and Identify Side Effects

Safety, Tolerability, and Dose-Limiting Toxicity of Lacosamide in Patients With Painful Chronic Pancreatitis: Protocol for a Phase 1 Clinical Trial to Determine Safety and Identify Side Effects

Authors of this article:

Evan L Fogel1 Author Orcid Image ;   Jeffrey J Easler1 Author Orcid Image ;   Ying Yuan2 Author Orcid Image ;   Dhiraj Yadav3 Author Orcid Image ;   Darwin L Conwell3 Author Orcid Image ;   Santhi Swaroop Vege4 Author Orcid Image ;   Samuel Y Han5 Author Orcid Image ;   Walter Park6 Author Orcid Image ;   Vanessa Patrick1 Author Orcid Image ;   Fletcher A White7 Author Orcid Image
Article Authors Cited by (1) Tweetations (4) Metrics
All Time | Last Month | Last Six Months | Last Year
There are currently no tweets available for this article within the specified range.